Literature DB >> 12910245

High-level generation of polyclonal antibodies by genetic immunization.

Ross S Chambers1, Stephen Albert Johnston.   

Abstract

Antibodies are important tools for investigating the proteome, but current methods for producing them have become a rate-limiting step. A primary obstacle in most methods for generating antibodies or antibody-like molecules is the requirement for at least microgram quantities of purified protein. We have developed a technology for producing antibodies using genetic immunization. Genetic immunization-based antibody production offers several advantages, including high throughput and high specificity. Moreover, antibodies produced from genetically immunized animals are more likely to recognize the native protein. Here we show that a genetic immunization-based system can be used to efficiently raise useful antibodies to a wide range of antigens. We accomplished this by linking the antigen gene to various elements that enhance antigenicity and by codelivering plasmids encoding genetic adjuvants. Our system, which was tested by immunizing mice with >130 antigens, has shown a final success rate of 84%.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12910245     DOI: 10.1038/nbt858

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  36 in total

1.  Distinct functions of the ubiquitin-proteasome pathway influence nucleotide excision repair.

Authors:  Thomas G Gillette; Shirong Yu; Zheng Zhou; Raymond Waters; Stephen Albert Johnston; Simon H Reed
Journal:  EMBO J       Date:  2006-06-07       Impact factor: 11.598

2.  Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.

Authors:  Baoxi Qu; Roger N Rosenberg; Liping Li; Philip J Boyer; Stephen A Johnston
Journal:  Arch Neurol       Date:  2004-12

3.  PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome.

Authors:  Inga Ebermann; Jennifer B Phillips; Max C Liebau; Robert K Koenekoop; Bernhard Schermer; Irma Lopez; Ellen Schäfer; Anne-Francoise Roux; Claudia Dafinger; Antje Bernd; Eberhart Zrenner; Mireille Claustres; Bernardo Blanco; Gudrun Nürnberg; Peter Nürnberg; Rebecca Ruland; Monte Westerfield; Thomas Benzing; Hanno J Bolz
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

4.  Generation of High-Specificity Antibodies against Membrane Proteins Using DNA-Gold Micronanoplexes for Gene Gun Immunization.

Authors:  Debra T Hansen; Felicia M Craciunescu; Petra Fromme; Stephen A Johnston; Kathryn F Sykes
Journal:  Curr Protoc Protein Sci       Date:  2018-02-21

5.  Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.

Authors:  In Ho Park; Ju Ho Youn; In-Hong Choi; Moon H Nahm; Se Jong Kim; Jeon-Soo Shin
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Genetic vaccination against murine cysticercosis by using a plasmid vector carrying Taenia solium paramyosin.

Authors:  Carlos F Solís; Pedro Ostoa-Saloma; Verónica H Lugo-Martínez; Stephen Albert Johnston; Juan Pedro Laclette
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  Polarized sorting of Patched enables cytoneme-mediated Hedgehog reception in the Drosophila wing disc.

Authors:  Laura González-Méndez; Ana-Citlali Gradilla; David Sánchez-Hernández; Esperanza González; Adrián Aguirre-Tamaral; Carlos Jiménez-Jiménez; Milagros Guerra; Gustavo Aguilar; Germán Andrés; Juan M Falcón-Pérez; Isabel Guerrero
Journal:  EMBO J       Date:  2020-04-20       Impact factor: 11.598

8.  Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.

Authors:  Bao-Xi Qu; Doris Lambracht-Washington; Min Fu; Todd N Eagar; Olaf Stüve; Roger N Rosenberg
Journal:  Vaccine       Date:  2010-06-04       Impact factor: 3.641

9.  Use of genetic immunization to generate a high-level antibody against rat dicarboxylate transporter.

Authors:  Guoshuang Xu; An Liu; Xiaowei Liu
Journal:  Int Urol Nephrol       Date:  2008-08-09       Impact factor: 2.370

10.  Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer.

Authors:  Dinesh Chandra; Arthee Jahangir; Francois Cornelis; Klara Rombauts; Lydie Meheus; Cheryl L Jorcyk; Claudia Gravekamp
Journal:  Oncoimmunology       Date:  2015-05-29       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.